GlassScriptPhysician profile
Eric L Fry
NPI 1538373485
$3,210.47
in general payments reported to CMS, 2019-2025
15 companies · $781 in 2025
The $781 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $663 · 2021: $784 · 2022: $434 · 2023: $378 · 2024: $169 · 2025: $781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,301 · Honoraria: $27.78.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,300.84 |
| Honoraria | $27.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $777.68 | 2019-2024 | Total30, Luxor |
| Carl Zeiss Meditec USA, INC. | $419.91 | 2023-2025 | Lumera 700 |
| Glaukos Corporation | $334.10 | 2019-2023 | Istent Infinite Trabecular Micro-Bypass System Model Is3, Is3-Istent Infinitetrabecular Micro-Bypass System Model Is3, Iaccess Precision Blade |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $304.40 | 2019-2021 | |
| Beaver-Visitec International, INC. | $280.04 | 2021-2023 | |
| Bausch & Lomb Americas INC. | $237.18 | 2022-2025 | Ic-8 Apthera Iol, Stellaris, Envista Mx60 Iol |
| Rxsight INC | $170.60 | 2023-2025 | Rxsight Contact Lens, Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Topcon Healthcare, INC. | $152.40 | 2025 | |
| Allergan, INC. | $143.06 | 2019 | |
| Regeneron Pharmaceuticals, INC. | $123.76 | 2025 | Eylea, Eylea Hd |
| Stryker Corporation | $109.64 | 2019 | |
| Galderma Laboratories, L.P. | $107.64 | 2019 | |
| The Cameron-Ehlen Group, INC. | $20.21 | 2022 | |
| Horizon Therapeutics Plc | $16.83 | 2022 | |
| Abbvie INC. | $13.02 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Fry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.